Shelter Pharma Limited (BOM:543963)
India · Delayed Price · Currency is INR 37.25
-0.75 (-1.97%)
At close: Sep 25, 2026
Shelter Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 627 | 446 | 418 | 568 | - | - | |
Market Cap Growth | 21.02% | 6.51% | -26.38% | - | - | - |
Enterprise Value | 624 | 405 | 370 | 532 | - | - |
Last Close Price | 37.25 | 26.83 | 35.91 | 48.44 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.22 | 4.94 | 5.78 | 9.17 | - | - |
PS Ratio | 0.86 | 0.61 | 0.83 | 1.42 | - | - |
PB Ratio | 0.82 | 0.58 | 0.98 | 1.59 | - | - |
P/TBV Ratio | 0.82 | 0.59 | 0.98 | 1.59 | - | - |
P/FCF Ratio | - | - | 15.09 | - | - | - |
P/OCF Ratio | - | - | 7.72 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.85 | 0.55 | 0.73 | 1.33 | - | - |
EV/EBITDA Ratio | 4.91 | 3.18 | 3.67 | 6.06 | - | - |
EV/EBIT Ratio | 5.06 | 3.28 | 3.77 | 6.23 | - | - |
EV/FCF Ratio | - | - | 13.33 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.12 | 0.02 |
Debt / EBITDA Ratio | 0.06 | 0.06 | 0.10 | 0.07 | 0.22 | 0.05 |
Debt / FCF Ratio | - | - | 0.38 | - | - | - |
Net Debt / Equity Ratio | 0.00 | 0.00 | -0.06 | -0.12 | 0.09 | 0.00 |
Net Debt / EBITDA Ratio | -0.02 | -0.02 | -0.24 | -0.51 | 0.17 | 0.01 |
Net Debt / FCF Ratio | 0.02 | 0.02 | -0.86 | 1.59 | -1.40 | -0.36 |
Asset Turnover | 1.10 | 1.10 | 1.18 | 1.35 | 2.11 | 2.61 |
Inventory Turnover | 2.98 | 2.98 | 3.25 | 3.23 | 3.85 | 5.35 |
Quick Ratio | 1.84 | 1.84 | 2.79 | 9.42 | 1.38 | 0.48 |
Current Ratio | 7.86 | 7.86 | 7.19 | 20.15 | 3.00 | 2.65 |
Return on Equity (ROE) | 15.13% | 15.13% | 18.43% | 24.62% | 44.35% | 22.84% |
Return on Assets (ROA) | 11.63% | 11.63% | 14.21% | 17.97% | 29.04% | 13.93% |
Return on Invested Capital (ROIC) | 11.93% | 15.61% | 20.45% | 27.03% | 47.78% | 23.91% |
Return on Capital Employed (ROCE) | 16.00% | 16.00% | 22.40% | 23.40% | 52.40% | 28.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 14.39% | 20.25% | 17.29% | 10.91% | - | - |
FCF Yield | -22.43% | -31.57% | 6.63% | -4.95% | - | - |
Dividend Yield | 0.94% | - | 0.97% | 0.68% | - | - |
Payout Ratio | 6.78% | 4.18% | 5.27% | - | - | - |
Buyback Yield / Dilution | -51.28% | -51.28% | - | -49.28% | - | -2.90% |
Total Shareholder Return | -50.34% | -51.28% | 0.97% | -48.60% | - | -2.90% |